NOVEMBER - 20206Alex D'SouzaManaging Editoreditor@medicaltechoutlook.comThe pharmaceutical industry has made great strides in recent years in developing drugs for unmet clinical needs. Perfecting the delivery of those drugs into the patients is also a significant aspect of the total pharmacotherapeutic regimen, and consequently, innovative ways to deliver these therapies are being developed as well. The increasing prevalence of chronic diseases, growth in the biologics market, and advancements in technology have been some of the other factors that have driven this innovation in drug delivery systems. The COVID-19 pandemic has also stimulated a sudden rise in demand for anti-infective pharmaceutical drugs, which is, in turn, reflecting on the drug delivery market.Today, scientists are very much committed to breaking down the barriers between the new drugs and their targets in tissues and cells. For instance, a broad range of nanoparticles is being developed to deliver new modalities to previously undruggable targets and to precisely control their release in formulations. Novel transdermal drug delivery systems, new drug delivery methods that reduce the need for multiple injections, and milk-derived exosome platforms are all some of the recent developments in the domain that depict this ongoing transformation in the drug delivery systems and technologies.In this edition of MedTech Outlook, we bring you the story of some of the most promising drug delivery device solution providers that deliver the best outcomes for their clients. This edition also offers a combination of thought leadership articles from subject matter experts and exclusive insights from CXOs. We hope this edition will provide you with the right assistance in choosing the best drug delivery device according to your requirements.Let us know your thoughts!Stepping into an Era of Innovative Drug DeliveriesEDITORIALNovember - 27 - 2020, volume 04 - Issue 23 (ISSN 2691-4093) Published by ValleyMedia, Inc. Managing EditorAlex D'SouzaEditorial StaffVisualizerRonald DonovanSalesAndrew D'Souzaandrew.dsouza@medicaltechoutlook.com510.996.5123Contact usEmailPhone:510 230 0396 Fax:510-894-8405sales@medicaltechoutlook.comeditor@medicaltechoutlook.commarketing@medicaltechoutlook.comJoshua Parker Merlin WatsonJoe Philip Laura PintoTo subscribe to MedicalTech OutlookVisit www.medicaltechoutlook.com Copyright © 2020 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffSarah Fernandes
< Page 5 | Page 7 >